Literature DB >> 19919080

First total synthesis of tubulysin B.

Orlando Pando1, Simon Dörner, Rainer Preusentanz, Annika Denkert, Andrea Porzel, Wolfgang Richter, Ludger Wessjohann.   

Abstract

The first total synthesis of tubulysin B is described. The aziridine route to tubuphenylalanine (Tup) of the tubulysin D/U-series could not be transferred to the synthesis of tubutyrosine (blue moiety). Therefore, tubutyrosine (Tut) was synthesized by a Wittig olefination/diastereoselective catalytic reduction sequence. Interestingly, the C-2 epimer of tubulysin B has a cytotoxic activity almost identical to the natural diastereomer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19919080     DOI: 10.1021/ol902320w

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  9 in total

Review 1.  Constructing molecular complexity and diversity: total synthesis of natural products of biological and medicinal importance.

Authors:  K C Nicolaou; Christopher R H Hale; Christian Nilewski; Heraklidia A Ioannidou
Journal:  Chem Soc Rev       Date:  2012-06-28       Impact factor: 54.564

2.  Chemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing mice.

Authors:  William C Floyd; Gopal K Datta; Shinichi Imamura; Heidi M Kieler-Ferguson; Katherine Jerger; Andrew W Patterson; Megan E Fox; Francis C Szoka; Jean M J Fréchet; Jonathan A Ellman
Journal:  ChemMedChem       Date:  2011-01-03       Impact factor: 3.466

3.  Prof. Ludger Wessjohann: A Lifelong Career Dedicated to a Remarkable Service in "Natural Products Sciences".

Authors:  Hidayat Hussain
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

4.  Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells.

Authors:  Michal Stark; Yehuda G Assaraf
Journal:  Oncotarget       Date:  2017-07-25

Review 5.  Antibody-drug conjugates: Recent advances in linker chemistry.

Authors:  Zheng Su; Dian Xiao; Fei Xie; Lianqi Liu; Yanming Wang; Shiyong Fan; Xinbo Zhou; Song Li
Journal:  Acta Pharm Sin B       Date:  2021-04-06       Impact factor: 11.413

6.  Diastereocontrol in Radical Addition to β-Benzyloxy Hydrazones: Revised Approach to Tubuvaline and Synthesis of O-Benzyltubulysin V Benzyl Ester.

Authors:  Manshu Li; Koushik Banerjee; Gregory K Friestad
Journal:  J Org Chem       Date:  2021-10-12       Impact factor: 4.354

7.  Pretubulysin: a new option for the treatment of metastatic cancer.

Authors:  S Braig; R M Wiedmann; J Liebl; M Singer; R Kubisch; L Schreiner; B A Abhari; E Wagner; U Kazmaier; S Fulda; A M Vollmar
Journal:  Cell Death Dis       Date:  2014-01-16       Impact factor: 8.469

8.  Pre-clinical evaluation of EC1456, a folate-tubulysin anti-cancer therapeutic.

Authors:  Joseph A Reddy; Ryan Dorton; Alicia Bloomfield; Melissa Nelson; Christina Dircksen; Marilynn Vetzel; Paul Kleindl; Hari Santhapuram; Iontcho R Vlahov; Christopher P Leamon
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

9.  Synthesis and antitumor activities of 3-substituted-analine derivatives: structure modifications of Tuv part of tubulysins.

Authors:  Mingsha Shao; Xinfa Bai; Xuan Ma; Ning Yan; Lei Yao
Journal:  Chem Cent J       Date:  2018-11-15       Impact factor: 4.215

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.